Human papillomavirus (HPV) vaccine coverage rates (VCRs) in France: A French claims data study - EHESP - École des hautes études en santé publique Access content directly
Journal Articles Vaccine Year : 2021

Human papillomavirus (HPV) vaccine coverage rates (VCRs) in France: A French claims data study


Background: The French Cancer Plan 2014-2019 had a target of 60% HPV vaccine coverage. The PAPILLON study investigated the annual age-specific vaccination initiation rates and cumulative partial and complete vaccination rates in France from 2017 to 2022. It also identified the factors associated with vaccination in different age groups and those associated with the type of completion of the vaccination scheme (partial vs full vaccination). Methods: For this publication, all females recorded in the French National Claims database who initiated HPV vaccination between 1 July 2007 and 31 December 2018 and were aged between 11 and 19 years at initiation were included. Annual HPV vaccination initiation rates were estimated in 11- to 14-year-old (target population) and 15- to 19-year-old females (catch-up). Cumulative vaccine coverage rates (VCRs) were estimated among those who were 15, 16, 20 and 21 years old. Partial vaccination was defined by dispensing of at least one dose of HPV vaccine by the pharmacy, while full vaccination was defined by two or three doses dispensed by a pharmacy over an 18-month period, according to current French recommendations based on the age at vaccination initiation. Results: Among the 465,629 females who initiated HPV vaccination in 2017 or 2018, the initiation rate increased from 7.7 to 11.1% in 11- to 14-year-old girls and from 4.5 to 6.5% in 15- to 19-year-old females. In 2017 and 2018, the cumulative VCRs for partial vaccination by age 15 were 28.2% and 32.8%, respectively, while by age 20, they were 41.6% and 38.8%. The cumulative VCRs for full vaccination were 15.6% and 18.6% by age 16, while they were 25.9 and 23.6% by age 20. HPV vaccination initiation and completion were strongly associated with the use of health services. Conclusion: Overall, the HPV VCR substantively increased between 2017 and 2018, which is positive evidence of the resumption of vaccination. Updates in 2022 should confirm these results.
No file

Dates and versions

hal-03312475 , version 1 (02-08-2021)



Faustine Dalon, Laureen Majed, Manon Belhassen, Flore Jacoud, Marjorie Bérard, et al.. Human papillomavirus (HPV) vaccine coverage rates (VCRs) in France: A French claims data study. Vaccine, 2021, ⟨10.1016/j.vaccine.2021.07.054⟩. ⟨hal-03312475⟩
68 View
0 Download



Gmail Mastodon Facebook X LinkedIn More